subject area of
- A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205 Journal Articles
- A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer Journal Articles
- Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial Journal Articles
- Actions of the muscle relaxant chandonium iodide on guinea-pig ileum and vas deferens preparations Journal Articles
- Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial Journal Articles
- Comparative Effectiveness of All Available Treatments for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-analysis Journal Articles
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer Journal Articles
- Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline Journal Articles
- Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide Journal Articles
- RETIRED: Oral Contraceptives and the Risk of Venous Thromboembolism: An Update Journal Articles
- Some actions of chandonium iodide, a new short‐acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations Journal Articles
- Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review Journal Articles